Latest filing published 12 May 2025 for Avantor, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Jonathan M. Peacock (board member) discloses dealings in 2 companies, chiefly Avantor, Inc. and Bellerophon Therapeutics, Inc. In total, 7 filings cover trades dated from 25 January 2016 to 8 May 2025.
No open-market sale appears; the market trades are 1 purchase worth €91k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants. So far in 2025, the count stands at 1 purchase and no sales.
The newest entry dates from 12 May 2025: a share grant, in Avantor, Inc. The clock since the last published purchase (29 April 2025) now reads 537 days. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations